ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 341 • 2014 ACR/ARHP Annual Meeting

    Death Receptor 3 Causes Vascular Dysfunction in a Murine Model of Rheumatoid Arthritis

    Jessica O Williams1, Eddie C.Y. Wang2, Derek Lang1 and Anwen S. Williams2, 1Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Cardiff, United Kingdom, 2Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

    Background/Purpose: Increased cardiovascular (CV) risk is prevalent in several forms of inflammatory arthritides. The mechanisms that regulate CV disease during early inflammatory arthritis are ill-defined.…
  • Abstract Number: 340 • 2014 ACR/ARHP Annual Meeting

    Role of Beta-Catenin Signaling to Control Dendritic Cell Function in Collagen-Induced Arthritis

    Celso Henrique Alves1,2, Julia L. Ober-Blöbaum3, Inge Brouwers-Haspels1,2, Patrick S. Asmawidjaja1,2, Anne-Marie Mus1,2, Björn E. Clausen3 and Erik Lubberts2,4, 1Rheumatology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 2Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 3Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany, 4Erasmus Medical Center, Rheumatology, Rotterdam, Netherlands

    Background/Purpose Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation and synovial infiltration of immune cells. T-cell priming by activated dendritic cells (DCs)…
  • Abstract Number: 339 • 2014 ACR/ARHP Annual Meeting

    Toll-like Receptor Dependent Autoantigens and Vesicles from P.Gingivalis in Animal Models of RA to Modulate Collagen and Collagen Antibody Induced Arthritis

    Christina Grimm1, Bianka Marklein1, Gerd Burmester1,2 and Karl Skriner3, 1Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany, 2Charité – University Medicine Berlin, Berlin, Germany, 3Department of Rheumatology and Clinical Immunology, Germany, Charité - Universitätsmedizin Berlin, Berlin, Germany

    Background/Purpose A variety of animal models suggest that TLR signaling is important in the pathogenesis of RA and the generation of specific autoantibodies. This study…
  • Abstract Number: 334 • 2014 ACR/ARHP Annual Meeting

    Inflammatory Arthritis in K/BxN Mice Is Associated with Abnormal HDL Function

    C. Charles-Schoeman1, Ani Shahbazian1, Yuen Yin Lee1 and Srinivasa T. Reddy2, 1Medicine-Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, 2Medicine-Cardiology, UCLA David Geffen School of Medicine, Los Angeles, CA

    Background/Purpose Patients with rheumatoid arthritis (RA) have significantly increased cardiovascular (CV) morbidity and mortality.  Abnormal function of high density lipoprotein (HDL) has been implicated as…
  • Abstract Number: 333 • 2014 ACR/ARHP Annual Meeting

    Deletion of the Prolactin Receptor Aggravates the Course of Antigen-Induced Arthritis

    Norma Adan, Maria G. Ledesma-Colunga, Ana L. Reyes-Lopez, Fernando Lopez-Barrera, Gonzalo Martinez de la Escalera and Carmen Clapp, Institute of Neurobiology, National University of Mexico (UNAM), Queretaro, Mexico

    Background/Purpose: Prolactin (PRL), the hormone essential for lactation, may protect against joint damage in rheumatoid arthritis. PRL frequently increases in the circulation of patients with…
  • Abstract Number: 332 • 2014 ACR/ARHP Annual Meeting

    Improvement of the Stability of RNA Aptamers Against Interleukin-17A

    Natsuki Otaki1, Asako Sasaki1, Shinsuke Hiramoto1, Masakazu Nagamine1, Shigeyuki Mori1, Tomoyoshi Kayo1, Kuniyoshi Hota1, Masayuki Takahashi1, Kazuhiko Haruta2 and Yoshikazu Nakamura3,4, 1Zenyaku Kogyo Co., Ltd., Tokyo, Japan, 22-33-7 Oizumi, Nerima, Zenyaku Kogyo Co., Ltd., Tokyo, Japan, 3Division of RNA Medical Science, The Institute of Medical Science, The University Of Tokyo, Tokyo, Japan, 4RIBOMIC Inc., Tokyo, Japan

    Background/Purpose Aptamers are RNA or DNA oligonucleotides selected for their capacity to specifically bind and inhibit the function of a target protein.  The effect is…
  • Abstract Number: 330 • 2014 ACR/ARHP Annual Meeting

    Prolactin Reduces Bone Erosion in Adjuvant-Induced Arthritis

    Maria G. Ledesma-Colunga, Norma Adan, Ana L. Reyes-Lopez, Fernando Lopez-Barrera, Gonzalo Martinez de la Escalera and Carmen Clapp, Institute of Neurobiology, National University of Mexico (UNAM), Queretaro, Mexico

    Background/Purpose Bone erosion is an important feature of rheumatoid arthritis (RA) that frequently results in lifelong crippling. The receptor activator of NFkB ligand (RANKL)/osteoprotegerin (OPG)/RANK…
  • Abstract Number: 329 • 2014 ACR/ARHP Annual Meeting

    A Novel, Small Molecule Cyclin-Dependent Kinase 4/6 Inhibitor As the New Option for Treatment of Rheumatoid Arthritis

    Hiroshi Takahashi1, Tsuyoshi Mizuno1, Toshimichi Nakamura1, Yuri Sakai1, Yumiko Muroga1, Kyohei Horie1, Naoki Hase1, Hitoshi Kohsaka2 and Tsuyoshi Kimura1, 1Teijin Pharma Limited, Hino,Tokyo, Japan, 2Department of Rheumatology, Graduate School of Medical and Dental Sciences,, Tokyo Medical and Dental University (TMDU), Tokyo, Japan

    Background/Purpose The pathogenesis of rheumatoid arthritis (RA) is characterized by infiltration of immune cells to the synovial tissues and their hyperplasia. Therapeutic strategies to inhibit…
  • Abstract Number: 328 • 2014 ACR/ARHP Annual Meeting

    Etanercept, Abatacept and Anakinra Treatment Ameliorates Inflammation and Pain in a Novel Mono-Arthritic Multi-Flare Model of Streptococcal Cell Wall Induced Arthritis: Further Characterization in a Rodent Model of Collagen Induced Arthritis

    Kalyan Chakravarthy1, Robert Faltus1, Anwar Murtaza1 and Milenko Cicmil2, 1Pharmacology, Merck Research Laboratories, Boston, MA, 2Merck Research Laboratories, Boston, MA

    Background/Purpose: We developed a novel mono-arthritic multi-flare Rat Streptococcal Cell Wall (SCW) model which captures certain aspects of disease with flares and remission of inflammation…
  • Abstract Number: 327 • 2014 ACR/ARHP Annual Meeting

    AMPK Activation in Inflammatory Arthritis

    Monica Guma1, Yun Wang2 and Ru Liu-Bryan2, 1Division of Rheumatology, Allergy and Immunology, University of California, San Diego, La Jolla, CA, 2UCSD/VAMC, La Jolla, CA

    Background/Purpose: AMP-activated protein kinase (AMPK) is a serine/threonine protein kinase involved in the regulation of cellular energy homeostasis. It is a central regulator of both…
  • Abstract Number: 326 • 2014 ACR/ARHP Annual Meeting

    IL-1 Receptor Antagonis (IL-1Ra)-Fc Ameliorate Autoimmune Arthritis By Regulation of the Th17 Cells/Treg Balance and Arthrogenic Cytokine Activation

    Hong Ki Min1, Sung Hwan Park2, Mi-La Cho3, Ji Hyeon Ju1, Seung-Ki Kwok4, Seon-Yeong Lee3, Seung Min Jung1, Kyung-Su Park5 and Jennifer Lee1, 1Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, South Korea, 3Rheumatism Research Center, Catholic Research Institute of Medical Science, Catholic University of Korea, Seoul, South Korea, 4Division of Rheumatology, Department of Internal Medicine, St. Mary’s hospital, The Catholic University of Korea, Seoul, South Korea, 5Internal Medicine, St. Vincent Hospital, SuWon Gyeonggi-do, South Korea

    Background/Purpose: : IL-1ß signalling has critical role on pathogenesis of various inflammatory arthritis including rheumatoid arthritis (RA). We aimed to investigate the therapeutic effects of…
  • Abstract Number: 325 • 2014 ACR/ARHP Annual Meeting

    Tadalafil Decreases Joint Inflammation in TNF-Tg Mice By Restoring Passive Lymphatic Transport

    Echoe M. Bouta1, Igor Kuzin2, Ronald Wood3, Christopher T. Ritchlin4, Andrea Bottaro2 and Edward M. Schwarz5, 1University of Rochester, Rochester, NY, 2Cooper Medical School, Camden, NJ, 3Department of Urology, University of Rochester Medical Center, Rochester, NY, 4Allergy Immunology & Rheumatology, University of Rochester Medical Center, Rochester, NY, 5Center for Musculoskeletal Research, University of Rochester, Rochester, NY

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory joint disease with enigmatic episodic flares.  Using longitudinal imaging, we recently demonstrated that arthritic knee flare in…
  • Abstract Number: 324 • 2014 ACR/ARHP Annual Meeting

    Regulation of TNF-α-Mediated Activation of Rheumatoid Synovial Fibroblasts By Transcription Factor Snail

    Chrong-Reen Wang1,2, Shih-Yao Chen3, Ai-Li Shiau4, I-Ming Jou5,6, Ming-Fei Liu1,2 and Chao-Liang Wu3, 1Internal Medicine, National Cheng Kung University Medical College, Tainan, Taiwan, 2Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan, 3Biochemistry and Molecular Biology, National Cheng Kung University Medical College, Tainan, Taiwan, 4Microbiology and Immunology, National Cheng Kung University Medical College, Tainan, Taiwan, 5Orthopedics, National Cheng Kung University Medical College, Tainan, Taiwan, 6Orthopedics, National Cheng Kung University Hospital, Tainan, Taiwan

    Background/Purpose: Transcription factor Snail plays active roles in various biological functions and is involved in many disease states. We hypothesized that this molecule regulates TNF-α-mediated…
  • Abstract Number: 323 • 2014 ACR/ARHP Annual Meeting

    Anti-Inflammatory Marine Compound, Lyy-B2, Ameliorates Rheumatoid Arthritis through Inhibition of Osteoclast Differentiation

    Yen-You Lin1, Hsin-Pai Lee1,2, Shi-Ying Huang1, Han-Chun Hung3, Chien-Wei Feng3, Chun-Hong Chen3, Jui-Hsin Su4,5, Ping-Jyun Sung4,5, Jyh-Horng Sheu1,3, Yen-Hsuan Jean2 and Zhi-Hong Wen1,3, 1Department of Marine Biotechnology and Resources, Asia-Pacific Ocean Research Center, National Sun Yat-Sen University, Kaohsiung, Taiwan, 2Section of Orthopedic Surgery, Pingtung Christian Hospital, Pingtung, Taiwan, 3Doctoral Degree Program in Marine Biotechnology, National Sun Yat-Sen University, Kaohsiung, Taiwan, 4Graduate Institute of Marine Biotechnology, National Dong Hwa University, Pingtung, Taiwan, 5Taiwan Coral Research Center, National Museum of Marine Biology & Aquarium, Pingtung, Taiwan

    Background/Purpose: Osteoclasts are multinucleated giant cells of macrophage/monocyte lineage, and are believed to play major roles in joint destruction caused by rheumatoid arthritis (RA). Nuclear…
  • Abstract Number: 322 • 2014 ACR/ARHP Annual Meeting

    Superior Therapeutic Efficacy of a Novel Oral Small Molecule Retinoic Acid Receptor-Related Orphan Receptor Gamma T [Rorgt] Inverse Agonist Inv-17: A Promising Safe & Efficacious Treatment for Rheumatoid Arthritis

    Anderson Gaweco1,2, Samantha Palmer1, Rambon Shamilov1, Caroline Stremnitzer1, Katie Matthews1, Michael Fisher1, William Windsor1, James Blinn1, Ellen M. Ginzler3 and Jefferson Tilley1, 1Innovimmune Biotherapeutics, Brooklyn, NY, 2SUNY-Downstate Medical Center, Brooklyn, NY, 3Rheumatology, SUNY-Downstate Medical Center, Brooklyn, NY

    Background/Purpose: T helper 17 [TH17] cells and its production of TH17 cytokines IL-17A and IL-17F play a critical role in the pathogenesis of RA and…
  • « Previous Page
  • 1
  • …
  • 2027
  • 2028
  • 2029
  • 2030
  • 2031
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology